{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:11:27Z","timestamp":1783152687528,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the General Projects of Social Development in Shaanxi Province","award":["No. 2022SF-565"],"award-info":[{"award-number":["No. 2022SF-565"]}]},{"name":"the Xi\u2019an Municipal Science and Technology Bureau","award":["24YXYJ0175"],"award-info":[{"award-number":["24YXYJ0175"]}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Program of Shaanxi","doi-asserted-by":"crossref","award":["No.2024SF2-GJHX-20"],"award-info":[{"award-number":["No.2024SF2-GJHX-20"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Second Affiliated Hospital of Air Force Medical University Discipline Boosting Plan \u2014Major Clinical Technology Innovation Project","award":["2025LCJS011"],"award-info":[{"award-number":["2025LCJS011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s43032-025-02039-7","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:55:39Z","timestamp":1767632139000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased Asialoglycoprotein Receptor 1 Level in Granulosa Cell as a Potential Biomarker for Polycystic Ovary Syndrome"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-4946","authenticated-orcid":false,"given":"Xitong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-818X","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"4","key":"2039_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120(4):767\u201393.","journal-title":"Fertil Steril"},{"key":"2039_CR2","doi-asserted-by":"crossref","unstructured":"Wild RA, et al. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073\u20139.e1-11.","DOI":"10.1016\/j.fertnstert.2010.12.027"},{"issue":"5","key":"2039_CR3","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1210\/jc.2013-3918","volume":"99","author":"A Roe","year":"2014","unstructured":"Roe A, et al. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J Clin Endocrinol Metab. 2014;99(5):E841\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2039_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2039_CR5","doi-asserted-by":"crossref","unstructured":"Jefcoate CR, Lee J. Cholesterol signaling in single cells: lessons from STAR and sm-FISH. J Mol Endocrinol. 2018;60(4):R213\u2013r235.","DOI":"10.1530\/JME-17-0281"},{"issue":"1\u20132","key":"2039_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0303-7207(02)00363-5","volume":"198","author":"WL Miller","year":"2002","unstructured":"Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002;198(1\u20132):7\u201314.","journal-title":"Mol Cell Endocrinol"},{"issue":"7922","key":"2039_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","volume":"608","author":"JQ Wang","year":"2022","unstructured":"Wang JQ, et al. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 2022;608(7922):413\u201320.","journal-title":"Nature"},{"issue":"10","key":"2039_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41569-022-00768-9","volume":"19","author":"K Huynh","year":"2022","unstructured":"Huynh K. ASGR1 inhibition stimulates cholesterol excretion. Nat Rev Cardiol. 2022;19(10):642.","journal-title":"Nat Rev Cardiol"},{"key":"2039_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117488","volume":"180","author":"J Song","year":"2024","unstructured":"Song J, et al. Beyond conventional treatment: ASGR1 leading the new era of hypercholesterolemia management. Biomed Pharmacother. 2024;180:117488.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2039_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4093\/dmj.2023.0124","volume":"48","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Deficiency of ASGR1 alleviates diet-induced systemic insulin resistance via improved hepatic insulin sensitivity. Diabetes Metab J. 2024;48(4):802\u201315.","journal-title":"Diabetes Metab J"},{"issue":"1","key":"2039_CR11","first-page":"55","volume":"36","author":"JM Lobaccaro","year":"2013","unstructured":"Lobaccaro JM, et al. Liver X receptors and female reproduction: when cholesterol meets fertility! J Endocrinol Invest. 2013;36(1):55\u201360.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2039_CR12","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10815-022-02598-7","volume":"39","author":"V Bellemare","year":"2022","unstructured":"Bellemare V, et al. Among high responders, is oocyte development potential different in Rotterdam consensus PCOS vs non-PCOS patients undergoing IVF? J Assist Reprod Genet. 2022;39(10):2311\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"2039_CR13","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/humrep\/deaf100","volume":"40","author":"AB Albert","year":"2025","unstructured":"Albert AB, et al. Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment. Hum Reprod. 2025;40(8):1562\u20139.","journal-title":"Hum Reprod"},{"issue":"2","key":"2039_CR14","first-page":"131","volume":"25","author":"S Trop-Steinberg","year":"2023","unstructured":"Trop-Steinberg S, et al. Omega-3 intake improves clinical pregnancy rate in polycystic ovary syndrome patients: a double-blind. Randomized Study Isr Med Assoc J. 2023;25(2):131\u20136.","journal-title":"Randomized Study Isr Med Assoc J"},{"issue":"1","key":"2039_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE TR, ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"6","key":"2039_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/CS20220408","volume":"137","author":"J Xing","year":"2023","unstructured":"Xing J, et al. Ferredoxin 1 regulates granulosa cell apoptosis and autophagy in polycystic ovary syndrome. Clin Sci. 2023;137(6):453\u201368.","journal-title":"Clin Sci"},{"issue":"4","key":"2039_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1095\/biolreprod.115.130690","volume":"93","author":"M Nie","year":"2015","unstructured":"Nie M, et al. miR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5. Biol Reprod. 2015;93(4):98.","journal-title":"Biol Reprod"},{"issue":"10","key":"2039_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/d41573-022-00153-8","volume":"21","author":"K Kingwell","year":"2022","unstructured":"Kingwell K. Inhibiting ASGR1 boosts cholesterol removal. Nat Rev Drug Discov. 2022;21(10):712.","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"2039_CR19","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","volume":"374","author":"P Nioi","year":"2016","unstructured":"Nioi P, et al. Variant ASGR1 associated with a reduced risk of coronary artery disease. N Engl J Med. 2016;374(22):2131\u201341.","journal-title":"N Engl J Med"},{"issue":"6","key":"2039_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942\u201360.","journal-title":"Hum Reprod Update"},{"key":"2039_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167\u201375.","journal-title":"Life Sci"},{"key":"2039_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147038","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.147038.","journal-title":"JCI Insight"},{"key":"2039_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144818","author":"JK Hoober","year":"2020","unstructured":"Hoober JK. ASGR1 and its enigmatic relative, CLEC10A. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21144818.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2039_CR24","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41467-024-46135-9","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, et al. Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress. Nat Commun. 2024;15(1):1908.","journal-title":"Nat Commun"},{"issue":"1","key":"2039_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01319-5","volume":"8","author":"W Zhao","year":"2023","unstructured":"Zhao W, Xu S, Weng J. ASGR1: an emerging therapeutic target in hypercholesterolemia. Signal Transduct Target Ther. 2023;8(1):43.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2039_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12916-023-02903-w","volume":"21","author":"G Yang","year":"2023","unstructured":"Yang G, Schooling CM. Genetically mimicked effects of ASGR1 inhibitors on all-cause mortality and health outcomes: a drug-target Mendelian randomization study and a phenome-wide association study. BMC Med. 2023;21(1):235.","journal-title":"BMC Med"},{"issue":"4","key":"2039_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015e,K \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015e K, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turk J Emerg Med. 2023;23(4):195\u20138.","journal-title":"Turk J Emerg Med"},{"issue":"1","key":"2039_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12916-023-03048-6","volume":"21","author":"N White","year":"2023","unstructured":"White N, et al. Evidence of questionable research practices in clinical prediction models. BMC Med. 2023;21(1):339.","journal-title":"BMC Med"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-02039-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:57:56Z","timestamp":1772204276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-02039-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-02039-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Institutional Review Board of Northwest Women\u2019s and Children\u2019s Hospital (IRB numbers: L2025-010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Patient consent was obtained before the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}